1
|
Rabe KF and Watz H: Chronic obstructive
pulmonary disease. Lancet. 389:1931–1940. 2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Duffy SP and Criner GJ: Chronic
obstructive pulmonary disease: Evaluation and management. Med Clin
North Am. 103:453–461. 2019.PubMed/NCBI View Article : Google Scholar
|
3
|
Lareau SC, Fahy B, Meek P and Wang A:
Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care
Med. 199:P1–P2. 2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Berg K and Wright JL: The pathology of
chronic obstructive pulmonary disease: Progress in the 20th and
21st centuries. Arch Pathol Lab Med. 140:1423–1428. 2016.PubMed/NCBI View Article : Google Scholar
|
5
|
Sorathia L: Palliative care in chronic
obstructive pulmonary disease. Med Clin North Am. 103:517–526.
2019.PubMed/NCBI View Article : Google Scholar
|
6
|
van Geffen WH, Kerstjens HAM and Slebos
DJ: Emerging bronchoscopic treatments for chronic obstructive
pulmonary disease. Pharmacol Ther. 179:96–101. 2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Aghapour M, Raee P, Moghaddam SJ, Hiemstra
PS and Heijink IH: Airway epithelial barrier dysfunction in chronic
obstructive pulmonary disease: Role of cigarette smoke exposure. Am
J Respir Cell Mol Biol. 58:157–169. 2018.PubMed/NCBI View Article : Google Scholar
|
8
|
Postma DS, Bush A and van den Berge M:
Risk factors and early origins of chronic obstructive pulmonary
disease. Lancet. 385:899–909. 2015.PubMed/NCBI View Article : Google Scholar
|
9
|
Barnes PJ: Inflammatory mechanisms in
patients with chronic obstructive pulmonary disease. J Allergy Clin
Immunol. 138:16–27. 2016.PubMed/NCBI View Article : Google Scholar
|
10
|
Sohal SS: Epithelial and endothelial cell
plasticity in chronic obstructive pulmonary disease (COPD). Respir
Investig. 55:104–113. 2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Butt Y, Kurdowska A and Allen TC: Acute
lung injury: A clinical and molecular review. Arch Pathol Lab Med.
140:345–350. 2016.PubMed/NCBI View Article : Google Scholar
|
12
|
Siganaki M, Koutsopoulos AV, Neofytou E,
Vlachaki E, Psarrou M, Soulitzis N, Pentilas N, Schiza S, Siafakas
NM and Tzortzaki EG: Deregulation of apoptosis mediators' p53 and
bcl2 in lung tissue of COPD patients. Respir Res.
11(46)2010.PubMed/NCBI View Article : Google Scholar
|
13
|
Chen Y, Luo H, Kang N, Guan C, Long Y, Cao
J, Shen Q, Li J, Yang M, Peng H and Chen P: Beraprost sodium
attenuates cigarette smoke extract-induced apoptosis in vascular
endothelial cells. Mol Biol Rep. 39:10447–10457. 2012.PubMed/NCBI View Article : Google Scholar
|
14
|
Yang M, Chen P, Peng H, Zhang H, Chen Y,
Cai S, Lu Q and Guan C: Cigarette smoke extract induces aberrant
cytochrome-c oxidase subunit II methylation and apoptosis in
human umbilical vascular endothelial cells. Am J Physiol Cell
Physiol. 308:C378–C384. 2015.PubMed/NCBI View Article : Google Scholar
|
15
|
Sun Y, An N, Li J, Xia J, Tian Y, Zhao P,
Liu X, Huang H, Gao J and Zhang X: miRNA-206 regulates human
pulmonary microvascular endothelial cell apoptosis via targeting in
chronic obstructive pulmonary disease. J Cell Biochem.
120:6223–6236. 2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Hombach S and Kretz M: Non-coding RNAs:
Classification, biology and functioning. Adv Exp Med Biol.
937:3–17. 2016.PubMed/NCBI View Article : Google Scholar
|
17
|
Novak J, Vašků JB and Souček M: Long
non-coding RNAs in the pathophysiology of atherosclerosis. Vnitr
Lek. 64:77–82. 2018.PubMed/NCBI(In Czech).
|
18
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016.PubMed/NCBI View Article : Google Scholar
|
19
|
Kok FO and Baker AH: The function of long
non-coding RNAs in vascular biology and disease. Vascul Pharmacol.
114:23–30. 2019.PubMed/NCBI View Article : Google Scholar
|
20
|
Zhang H, Sun D, Li D, Zheng Z, Xu J, Liang
X, Zhang C, Wang S, Wang J and Lu W: Long non-coding RNA expression
patterns in lung tissues of chronic cigarette smoke induced COPD
mouse model. Sci Rep. 8(7609)2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Tang W, Shen Z, Guo J and Sun S: Screening
of long non-coding RNA and TUG1 inhibits proliferation with TGF-β
induction in patients with COPD. Int J Chron Obstruct Pulmon Dis.
11:2951–2964. 2016.PubMed/NCBI View Article : Google Scholar
|
22
|
Gu W, Yuan Y, Wang L, Yang H, Li S, Tang Z
and Li Q: Long non-coding RNA TUG1 promotes airway remodelling by
suppressing the miR-145-5p/DUSP6 axis in cigarette smoke-induced
COPD. J Cell Mol Med. 23:7200–7209. 2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Li D, Hu J, Wang T, Zhang X, Liu L, Wang
H, Wu Y, Xu D and Wen F: Silymarin attenuates cigarette smoke
extract-induced inflammation via simultaneous inhibition of
autophagy and ERK/p38 MAPK pathway in human bronchial epithelial
cells. Sci Rep. 6(37751)2016.PubMed/NCBI View Article : Google Scholar
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
25
|
Yang D, Yu J, Liu HB, Yan XQ, Hu J, Yu Y,
Guo J, Yuan Y and Du ZM: The long non-coding RNA TUG1-miR-9a-5p
axis contributes to ischemic injuries by promoting cardiomyocyte
apoptosis via targeting KLF5. Cell Death Dis.
10(908)2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Riley CM and Sciurba FC: Diagnosis and
outpatient management of chronic obstructive pulmonarydisease: A
review. JAMA. 321:786–797. 2019.PubMed/NCBI View Article : Google Scholar
|
27
|
Lin YH, Tsai CL, Tsao LI and Jeng C: Acute
exacerbations of chronic obstructive pulmonary disease (COPD)
experiences among COPD patients with comorbid gastrooesophageal
reflux disease. J Clin Nurs. 28:1925–1935. 2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Concannon CG, Tuffy LP, Weisová P, Bonner
HP, Dávila D, Bonner C, Devocelle MC, Strasser A, Ward MW and Prehn
JH: AMP kinase-mediated activation of the BH3-only protein Bim
couples energy depletion to stress-induced apoptosis. J Cell Biol.
189:83–94. 2010.PubMed/NCBI View Article : Google Scholar
|
29
|
Kilbride SM, Farrelly AM, Bonner C, Ward
MW, Nyhan KC, Concannon CG, Wollheim CB, Byrne MM and Prehn JH:
AMP-activated protein kinase mediates apoptosis in response to
bioenergetic stress through activation of the pro-apoptotic Bcl-2
homology domain-3-only protein BMF. J Biol Chem. 285:36199–36206.
2010.PubMed/NCBI View Article : Google Scholar
|
30
|
Crowley LC and Waterhouse NJ: Detecting
cleaved caspase-3 in apoptotic cells by flow cytometry. Cold Spring
Harb Protoc: Nov 1, 2016 (Epub ahead of print). doi:
10.1101/pdb.prot087312.
|
31
|
Rogers C, Fernandes-Alnemri T, Mayes L,
Alnemri D, Cingolani G and Alnemri ES: Cleavage of DFNA5 by
caspase-3 during apoptosis mediates progression to secondary
necrotic/pyroptotic cell death. Nat Commun. 8(14128)2017.PubMed/NCBI View Article : Google Scholar
|